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intial observation that mutation of the IFT protein IFT88/ polaris in the Tg737 mouse model of autosomal dominant PKD (ADPKD) led to shortened cilia in the kidney [Pazour et al., 2000] . Subsequently, it was established that the polypeptides encoded by genes mutated in human ADPKD such as polycystin 2 localized to primary cilia in renal epithelia [Yoder et al., 2002] . To date, more than thirty different genes have been identified that, when mutated, give rise to renal cystic cilia-related disease (ciliopathies), and the majority of these localize to cilia and/or centrosomes. It is also becoming evident that many of these genes encode proteins that physically interact with other ciliopathy proteins to form large macromolecular complexes required for correct cilia function. This has been nicely demonstrated for the ciliopathy BBS, where proteomic analysis revealed a complex consisting of the BBS1, BBS2, BBS4, BBS5, BBS7, BBS8 and BBS9 proteins [Nachury et al., 2007] . In this review, we will focus on the ciliopathy NPHP.
Nephronophthisis
NPHP is an autosomal recessive kidney disease that is the most common cause of inheritable end-stage renal failure (ESRF) in the first three decades of life, with the median onset of ESRF being at 13 years. The disease can be subdivided clinically based on the age of onset of ESRF into infantile, juvenile and adolescent categories with the median age of onset being 1, 13 and 19 years of age, respectively. Prior to ESRF, clinical symptoms include polyuria, polydipsia and anemia. Kidneys from NPHP patients are generally normal or reduced in size. Histologically, they display sporadic cysts at the corticomedullary junction, tubular basement membrane disruption, periglomerular fibrosis and tubulointerstitial cell infiltrates with interstitial fibrosis.
NPHP1 Deletions Cause a Limited Disease
To date, through the use of positional cloning, mutations in twelve genes ( NPHP1-11 and NPHPL1 ) have been demonstrated to give rise to NPHP ( table 1 ) . However, these genes only account for approximately 30% of cases of NPHP. So it is likely that many more causative genes will be identified in the future. The first identified NPHP gene was NPHP1 that encodes the protein nephrocystin-1, which is mutated in approximately 20% of all cases of NPHP. Homozygous deletions of the NPHP1 gene were identified in individuals with juvenile NPHP type 1 [Hildebrandt et al., 1997] . This protein was first described to localize to epithelial cell-cell contacts [Donaldson et al., 2000 [Donaldson et al., , 2002 , but was later additionally localized to the cilia transition zone [Fliegauf et al., 2006] . Interestingly, this localization requires the interaction of NPHP1 with the trafficking protein PACS1 which is also involved in the trafficking of the ADPKD protein polycystin 2 Schermer et al., 2005] .
NPHP2 Mutations Cause Infantile NPHP
The NPHP2 gene encodes the inversin protein and is mutated in infantile NPHP . Unusually, unlike the other NPHP genes, individuals harboring mutations in inversin have slightly enlarged kidneys that more closely resemble kidneys from PKD patients. In addition, patients may display situs inversus and cardiac ventricular septal defects. Like nephrocystin-1, inversin also localizes to the proximal part of the cilium [Shiba et al., 2009] . Of all the NPHP genes, the causative disease mechanism associated with inversin is the best understood. Pioneering work by Simons et al. [2005] showed that cilia are essential for the regulation of planar cell polarity and that inversin plays a central role in this process. Inversin acts at a fulcrum between the Wnt-mediated canonical and noncanonical pathways. Loss of inversin function through its mutation results in enhanced noncanonical Wnt signaling and abrogated planar cell polarity. Planar cell polarity specifies the orientation of a cell with regards to neighboring cells and is essential for normal tissue formation and maintenance. It is thought that cyst formation, especially in PKD, results from randomized orientation of epithelial cell division that leads to ductal expansion [Fischer et al., 2006; Verdeguer et al., 2010] .
Mutations of NPHP3 , -4 and -5 Cause Retinal-Renal Ciliopathies
Mutations of the NPHP3 gene which encodes nephrocystin 3 have been found in patients with adolescent NPHP [Olbrich et al., 2003; Tory et al., 2009] . A missense mutation of Nphp3 also causes the renal cystic mouse phenotype PCY [Olbrich et al., 2003 ]. Similar to inversin, nephrocystin 3 localizes to the proximal region of primary cilia, and this localization requires its interaction with inversin [Shiba et al., 2010] . In addition, nephrocystin 3 also forms a complex with nephrocystin 1. The function of nephrocystin 3 is not clear, but it is fundamental to cilia function as truncating mutations of NPHP3 in both humans and mice result in extremely severe multiorgan dysfunction as a result of embryonic patterning defects which closely resemble those observed in MeckelGruber syndrome (MKS) [Bergmann et al., 2008] .
The nephrocystin 4 protein encoded by the NPHP4 gene, which is mutated in juvenile NPHP, localizes to the cilia transition zone as well as to the cortical actin cytoskeleton of epithelia [Mollet et al., 2005; Winkelbauer et al., 2005] . It is thought that NPHP4 in conjunction with NPHP1 may function at the transition zone to regulate entry and exit of ciliary cargos [Winkelbauer et al., 2005] . More recently, NPHP4, again in conjunction with NPHP1, was deemed essential in regulating cellular apicobasal polarity via interactions with the evolutionarily conserved PALS1/PATJ/Crb3 polarity complex [Delous et al., 2009] . Apicobasal polarity of epithelia is essential for formation of cell-cell contacts known as tight junctions which prevent paracellular movement of molecules across epithelia, as well as for cilia formation. However, it is not clear whether the primary etiology of NPHP is due to abnormal cell polarity or cilia dysfunction. NPHP4 has also been demonstrated to interact with two other ciliopathy proteins, RPGRIP and RPGRIP1L, which are mutated in Leber congenital amaurosis and cerebello-oculo-renal syndrome (Joubert syndrome, JS) respectively. Mutations in RPGRIP1L were found to give rise to NPHP [Arts et al., 2007; Delous et al., 2009] .
Similar to NPHP4, the NPHP5 gene product IQCB1 also localizes to primary cilia. In addition, it interacts with the retinal ciliopathy gene RPGR (retinitis pigmentosa GTPase regulator) which is mutated in the majority of cases of X-linked retinitis pigmentosa . IQCB1 contains a calmodulin-binding IQ domain, and does in fact directly interact with calmodulin. However, the functional significance of this interaction is not clear. Although renal cilia regulate intracellular calcium levels in response to fluid flow, it is likely that calcium and calmodulin regulate many aspects of cilia formation and function.
Since mutation of any one NPHP gene closely recapitulates the phenotype of mutations in other NPHP genes, together with the fact that most of these proteins are localized to cilia and centrosomes, it is highly likely that the nephrocystin proteins form supramolecular complexes that are necessary for cilia formation and function. Indeed, the IQCB1 protein directly interacts with CEP290/NPHP6 [Schafer et al., 2008] . This is further supported by the fact that like NPHP5, NPHP6 also forms a complex with RPGR [Chang et al., 2006] . An additional level of complexity was revealed by the direct interaction and subsequent activation of NPHP6 with the cAMP-regulated transcription factor CREB2/ ATF4 [Sayer et al., 2006] . It has been known for some time that elevated cAMP levels are observed in epithelia from cystic kidneys [Wang et al., 2010] , and this observation was the first to provide evidence that abnormal gene expression may contribute to disease progression of NPHP. Knockdown of Cep290/NPHP6 in zebrafish recapitulated the JS phenotype seen in humans and demonstrated a planar cell polarity phenotype.
A signaling mechanism that was more recently demonstrated to be linked to primary cilia is the hedgehog pathway. Hedgehog signaling is crucial during embryogenesis as it controls tissue patterning and cell fate specification. The hedgehog receptor Patched localizes to primary cilia, and upon hedgehog binding subsequently traffics out of the cilia allowing the protein Smoothened (Smo) to reside in the cilium [May et al., 2005; Ocbina and Anderson, 2008] . Ciliary Smo then promotes the conversion of Gli transcription factors, which also localize to cilia, to the activator forms that when trafficked to the nucleus drive expression of hedgehog responsive genes. In the case of NPHP, a related transcription factor Glisimilar 2 was found to be mutated in NPHP type 7 [Attanasio et al., 2007] . Mutation of the NPHP7 locus in mice resulted in many of the hallmark histological features of NPHP such as renal atrophy and prominent fibrosis [Attanasio et al., 2007] . Loss of Gli-similar 2 resulted in a transcriptional switch that led to upregulation of genes that promote epithelial to mesenchymal transition, potentially providing an explanation for the fibrosis associated with NPHP. This observation together with the association of NPHP6 and ATF4 again highlighted the central role that NPHP proteins may play in maintenance of normal kidney function through the regulation of gene expression.
Although PKD and NPHP have markedly different histological features, the gene products involved share a common subcellular distribution -the cilia and centrosomes. A further connection was established upon the identification of the NPHP9 locus. The NPHP9 gene encodes the kinase NEK8 which localizes to the proximal part of the cilium. NPHP causative mutations resulted in mislocalization of NEK from this region [Otto et al., 2008] . In a subsequent study, it was found that NEK8 interacts with the ADPKD protein polycystin 2 and suggested that NEK8 may regulate both the expression and posttranslational modification (phosphorylation) of both polycystin 1 and polycystin 2 [Sohara et al., 2008] . It has also been shown that NPHP2 , which when mutated gives a PKD-like kidney phenotype, is required for targeting of NEK8 to the primary cilium [Shiba et al., 2010] . It is likely that more such connections involving the cilia-centrosome complex will be subsequently found between genes involved in the hyperplastic phenotype of PKD and the dysplastic phenotype of NPHP.
Most recently, we have demonstrated that not all NPHP genes localize to primary cilia or centrosomes. Using genome-wide homozygosity mapping, we identified a new NPHP locus in two families with NPHP-like symptoms. The NPHP-like 1 gene (NPHPL1) encodes the enzyme X-prolyl aminopeptidase 3 (XPNPEP3) which, contrary to the current ciliopathy paradigm, localizes to mitochondria via a mitochondrial leader sequence. However, whilst XPNPEP3 does not localize to cilia, it may modulate cilia function through proteolytic cleavage of a number of cilia proteins harboring compatible proteolytic target motifs [O'Toole et al., 2010] .
Extrarenal Phenotypes and Allelism
As previously discussed, cilia are highly conserved organelles whose function may be modified by the incorporation of additional tissue-specific proteins that modulate their cell type-specific function. This requirement for the same core protein complexes that underlie cilia function between different cell types results in syndromic ciliopathies, where multiple ciliated tissues are effected by mutation of a single gene. This is especially true of nephropthisis, which is often associated with extrarenal manifestations.
Senior-Løken Syndrome
One of the most common extrarenal manifestations associated with NPHP is retinal degeneration. Both rod and cone photoreceptors have specialized cilium that act to connect the inner and outer segments. Initially during retinal morphogenesis, photoreceptor cells contain a single primary cilium that closely resembles the one seen on many other cell types. However, the cilia membrane of photoreceptors becomes highly specialized through delivery of material to and expansion of the ciliary distal tip. Compared to the cilia of other cell types, the photoreceptor e13 connecting cilium likely experiences particularly high traffic due to turnover of rhodopsin and light-dark adaptation. As such, photoreceptors are likely to be overtly sensitive to mutations that effect cilia function/trafficking. In fact, nephronophthisis is often associated with retinal degeneration due to mutation of cilia-associated proteins. Senior-Løken syndrome (SLS) is a renal-retinal disorder caused by mutations in the several of the NPHP genes. All patients with mutations in the NPHP5 gene and approximately 30% of patients with mutations in NPHP4 or NPHP9 exhibit SLS. Recently, we have also identified mutations in a new gene NPHP10/SDCCAG8. Like many of the other NPHP genes, SDCCAG8 is a centrosomal-associated protein which directly interacts with the ciliopathy protein OFD1. Most patients with NPHP10 mutations exhibit SLS, but a few additionally display some features of BBS such as obesity and mild mental retardation. .
Joubert Syndrome and Meckel-Gruber Syndrome
Similar to SLS, JS results in renal-retinal manifestations but with accompanied cerebellar vermis hypoplasia. JS patients therefore exhibit multiple neurological defects such as ataxia and mental retardation. JS can be caused by recessive mutations in each of multiple different NPHP genes including NPHP1, NPHP3, NPHP6 and NPHP8 . A further syndromic ciliopathy with multi-organ involvement is MKS. MKS is a recessive disorder that results in prenatal lethality due to multiple organ dysplasia including kidney (kidney cysts), retina (microphthalmia), brain (occipital meningoencephalocele), liver (hepatic cysts) and limbs (postaxial polydactyly). Of the NPHP genes, MKS can be caused by recessive mutations in either NPHP3 , NPHP6 or NPHP8 .
It is becoming clear that mutations in a specific NPHP gene do not always correlate with a specific genotype/ phenotype. Mutations in one gene such as NPHP5/ CEP290 can give rise to a broad spectrum of phenotypes from NPHP with no extrarenal manifestations through to JS or MKS. The severity of the phenotype may be linked to the type of mutations/alleles present, such that severe mutations (truncating/null) would give rise to severe disease (such as MKS) and hypomorphic (missense) alleles give rise to milder disease (NPHP). This alleism effect may also be relevant to disease progression, where severe alleles result in an early-onset phenotype due to developmental defects (organ formation/patterning) and milder alleles give rise to later-onset degenerative defects (apoptosis/fibrosis). With the advent of high-throughput sequencing techniques, it is likely that the list of causative genes and mutations will continue to grow.
